Insights Into Ovarian Cancer

Perspectives on current treatment practices in the management of ovarian cancer with regard to molecular testing and first-line and maintenance therapy options

Northwest December 17, 2020

Faculty Chair

Dan Veljovich, MD

Swedish Cancer Institute, Seattle, WA

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated, virtual roundtable discussion focusing on the treatment of ovarian cancer was held on December 17, 2020
  • Disease state and data presentations were developed in conjunction with Dr Dan Veljovich from Swedish Cancer Institute ​
  • The group of advisors comprised 8 community oncologists who treat patients with ovarian cancer
  • Insights on the following therapies were obtained: chemotherapies (platinums, taxanes), olaparib, niraparib, bevacizumab

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • Attendees of the roundtable represented community oncologists from Washington, Wyoming, and California

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.